Condor Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,379
| Closed | -$375K | – | 221 |
|
|
2022
Q4 | $375K | Buy |
3,379
+139
| +4% | +$14.2K | 0.05% | 165 |
|
|
2022
Q3 | $279K | Buy |
3,240
+9
| +0.3% | +$803 | 0.04% | 175 |
|
|
2022
Q2 | $295K | Sell |
3,231
-1,445
| -31% | -$128K | 0.04% | 170 |
|
|
2022
Q1 | $384K | Sell |
4,676
-445
| -9% | -$35.1K | 0.04% | 162 |
|
|
2021
Q4 | $392K | Sell |
5,121
-917
| -15% | -$73K | 0.04% | 161 |
|
|
2021
Q3 | $454K | Sell |
6,038
-54
| -0.9% | -$4.11K | 0.05% | 168 |
|
|
2021
Q2 | $474K | Sell |
6,092
-284
| -4% | -$21.1K | 0.05% | 164 |
|
|
2021
Q1 | $469K | Sell |
6,376
-202
| -3% | -$14.9K | 0.06% | 160 |
|
|
2020
Q4 | $513K | Buy |
6,578
+4
| +0.1% | +$306 | 0.06% | 153 |
|
|
2020
Q3 | $520K | Sell |
6,574
-1,441
| -18% | -$113K | 0.08% | 143 |
|
|
2020
Q2 | $591K | Buy |
8,015
+269
| +3% | +$20.3K | 0.09% | 143 |
|
|
2020
Q1 | $569K | Buy |
7,746
+2,878
| +59% | +$226K | 0.11% | 137 |
|
|
2019
Q4 | $423K | Buy |
4,868
+9
| +0.2% | +$739 | 0.06% | 154 |
|
|
2019
Q3 | $390K | Buy |
4,859
+7
| +0.1% | +$561 | 0.06% | 154 |
|
|
2019
Q2 | $388K | Buy |
4,852
+6
| +0.1% | +$459 | 0.06% | 158 |
|
|
2019
Q1 | $385K | Buy |
4,846
+143
| +3% | +$10.7K | 0.06% | 158 |
|
|
2018
Q4 | $343K | Buy |
4,703
+6
| +0.1% | +$424 | 0.06% | 163 |
|
|
2018
Q3 | $318K | Buy |
4,697
+7
| +0.1% | +$446 | 0.06% | 153 |
|
|
2018
Q2 | $272K | Sell |
4,690
-96
| -2% | -$5.42K | 0.05% | 157 |
|
|
2018
Q1 | $249K | Sell |
4,786
-66
| -1% | -$3.56K | 0.05% | 157 |
|
|
2017
Q4 | $261K | Sell |
4,852
-203
| -4% | -$11.3K | 0.05% | 153 |
|
|
2017
Q3 | $309K | Buy |
5,055
+216
| +4% | +$13.1K | 0.06% | 153 |
|
|
2017
Q2 | $296K | Buy |
4,839
+8
| +0.2% | +$487 | 0.06% | 155 |
|
|
2017
Q1 | $293K | Buy |
4,831
+111
| +2% | +$6.73K | 0.06% | 155 |
|
|
2016
Q4 | $265K | Buy |
4,720
+6
| +0.1% | +$351 | 0.06% | 160 |
|
|
2016
Q3 | $281K | Sell |
4,714
-64
| -1% | -$3.74K | 0.07% | 159 |
|
|
2016
Q2 | $263K | Buy |
4,778
+8
| +0.2% | +$426 | 0.06% | 161 |
|
|
2016
Q1 | $241K | Buy |
4,770
+7
| +0.1% | +$343 | 0.06% | 157 |
|
|
2015
Q4 | $240K | Buy |
4,763
+7
| +0.1% | +$353 | 0.06% | 166 |
|
|
2015
Q3 | $224K | Buy |
4,756
+6
| +0.1% | +$319 | 0.06% | 170 |
|
|
2015
Q2 | $258K | Sell |
4,750
-134
| -3% | -$7.51K | 0.06% | 167 |
|
|
2015
Q1 | $268K | Buy |
4,884
+7
| +0.1% | +$396 | 0.06% | 168 |
|
|
2014
Q4 | $264K | Buy |
4,877
+110
| +2% | +$6.13K | 0.07% | 150 |
|
|
2014
Q3 | $270K | Buy |
4,767
+6
| +0.1% | +$337 | 0.08% | 145 |
|
|
2014
Q2 | $263K | Buy |
4,761
+269
| +6% | +$14.7K | 0.07% | 144 |
|
|
2014
Q1 | $243K | Sell |
4,492
-98
| -2% | -$5.08K | 0.07% | 145 |
|
|
2013
Q4 | $219K | Buy |
4,590
+7
| +0.2% | +$320 | 0.07% | 146 |
|
|
2013
Q3 | $208K | Sell |
4,583
-120
| -3% | -$5.48K | 0.07% | 149 |
|
|
2013
Q2 | $208K | Buy |
+4,703
| New | +$210K | 0.08% | 154 |
|
Other funds holding MRK
Condor Capital Management's MRK Position: Q1 2023 in Review
Condor Capital Management sold out of Merck (MRK) in Q1 2023, closing a stake of 3,379 shares — an estimated $375K sold.
Condor Capital Management first reported a position in MRK in Q2 2013 and held it in 39 quarters. The position peaked at $591K in Q2 2020. 3,179 funds tracked by Wall St. Rank hold MRK as of Q1 2023.
- Condor Capital Management reported no remaining Merck position as of Q1 2023 after selling out during the quarter.
- Condor Capital Management sold 3,379 Merck shares in Q1 2023, an estimated $375K.
- Condor Capital Management first reported a position in Merck in Q2 2013 and held it in 39 quarters.
- Condor Capital Management's Merck position peaked at $591K in Q2 2020.
- 3,179 funds tracked by Wall St. Rank held Merck as of Q1 2023.
Based on Condor Capital Management's 13F filing for Q1 2023, filed 10 May 2023.